Comparing the levels of SLC34A2 expression between relatively healthy and tumor tissues (Wilcoxon test, p < 0.05), the higher levels of expression were found in tumor tissues of the myeloid, bowel, ovary, and uterus, and the lower levels were found in samples of breast, liver, lung, and skin tumors (Figure 2). The gene discussed is SLC34A2; the disease is skin neoplasm.